Dongfeng

Jiangsu Dongfeng Pharmaceutical Co., Ltd. is a prominent Chinese pharmaceutical manufacturer and a key subsidiary of the Shanghai Fosun Pharmaceutical (Group) Co., Ltd. Established in 1970 and based in Lianyungang, the company specializes in the production of chemical drug products across several therapeutic areas, including anti-infectives, cardiovascular health, and metabolism. Its extensive portfolio features widely used generic medications such as amoxicillin, gliclazide, and amlodipine, as well as various active pharmaceutical ingredients (APIs). As an integral part of Fosun Pharma's industrial chain, Jiangsu Dongfeng operates large-scale, GMP-certified manufacturing facilities that serve both domestic and international markets. The company plays a vital role in providing affordable, high-quality essential medicines and supports the broader R&D and commercialization strategies of its parent organization.